Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tigeryeah Capital

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
The average size of a deal this fund participated in
Portfolio companies 10
Rounds per year 1.38
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon

Areas of investment

  • Medical
  • Health Care
  • Medical Device
  • Biotechnology
  • Professional Services

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Tigeryeah Capital:
Typical Co-investors
Tigeryeah Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Tigeryeah Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BOD Tech Ventures -
CHANEL France, Ile-de-France, Neuilly-sur-seine
codecentric AG Düsseldorf, Germany, Nordrhein-Westfalen
Cyrus Poonawalla Group India, Maharashtra, Pune
Fairview Health Services Minneapolis, Minnesota, United States
Flexible Funding -
Gallo Digital -
Gryphon Investments Chesterfield, Missouri, United States
Heshi Jiye China, Qingpu, Shanghai
Incepta Group England, London, United Kingdom
Jordan Engineering -
Lakewest Venture Partners Chicago, Illinois, United States
LS Polaris Innovation Fund -
NBGI Ventures England, London, United Kingdom
Superangel Estonia, Harjumaa, Tallinn
The Pearl Fund -
Thorney Investment Australia, Melbourne, Victoria
Unum Group Chattanooga, Tennessee, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tingsheng Technology

Health Care
Medical Device
$15M03 Mar 2022 Nanjing, Jiangsu, China

Enze Kangtai

11 Jan 2022 Changping, Beijing, China


Medical Device
$15M27 Dec 2021 Suzhou, Jiangsu, China

Hangzhou DAC Biotech Co., Ltd

Health Care
$154M12 May 2021 Shangcheng District, Zhejiang, China


Health Care
$15M14 Jan 2021 Gusu District, Jiangsu, China

Insight Lifetech

$27M30 Dec 2020 Shenzhen, Guangdong, China


Health Care
Professional Services
$3M03 Apr 2020 Haidian District, Beijing, China

Hanyu Medical

Health Care
Medical Device
12 Apr 2018 Shanghai, China


Information Technology
$463K30 Sep 2017 Haidian District, Beijing, China


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tigeryeah Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: